Radius Recycling downgraded by Seaport Research Partners with a new price target
$RDUS
Industrial Specialties
Consumer Discretionary
Seaport Research Partners downgraded Radius Recycling from Neutral to Sell and set a new price target of $17.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/2/2024 | $22.00 | Neutral | Goldman |
| 5/30/2024 | Sell → Neutral | Seaport Research Partners | |
| 2/28/2024 | $17.50 | Neutral → Sell | Seaport Research Partners |
| 12/14/2023 | Neutral | Seaport Research Partners | |
| 6/8/2022 | $8.00 | Underperform → Neutral | BofA Securities |
| 5/23/2022 | $7.00 | Mkt Perform | SVB Leerink |
| 12/10/2021 | $18.00 → $7.00 | Equal-Weight → Underweight | Morgan Stanley |
| 12/10/2021 | $33.00 → $12.00 | Buy → Neutral | Goldman Sachs |
Ferrous and Finished Steel Sales Volumes Up Year-Over-Year Positive Operating and Free Cash Flow Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) ("Radius" or the "Company") today reported results for the second quarter of fiscal 2025 ended February 28, 2025. The Company reported a loss per share from continuing operations of $(1.15) and a net loss of $(33) million in the second quarter of fiscal 2025, compared to ($1.19) and ($34) million, respectively, in the prior year second quarter. Adjusted EBITDA was approximately break-even in the second quarter of fiscal 2025, compared to $3 million in the prior ye
Radius Recycling Shareholders to Receive $30.00 in Cash Per Share, Delivering Significant Value TTC's Investments to Accelerate Radius Recycling's Growth Strategies and Strengthen Resiliency TTC Committed to Honoring Collective Bargaining Agreements and Compensation and Benefits Programs for All Radius Recycling Employees PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) ("Radius" or the "Company") today announced that it has entered into a definitive merger agreement with Toyota Tsusho America, Inc. ("TAI"), a U.S. subsidiary of Toyota Tsusho Corporation (8015.T) ("TTC"), under which TAI will acquire all shares of Radius for $30.00 per share
GREENWICH, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- QXO, Inc. (NYSE:QXO) announced today that it has informed Beacon Roofing Supply, Inc. (NASDAQ:BECN) that it will propose 10 independent director nominees at Beacon's 2025 Annual Meeting of Shareholders to replace Beacon's Board of Directors. The slate of independent nominees includes current and former senior executives and directors of leading global companies who were selected for their deep expertise with large-scale corporate transformations, extensive knowledge of the building products and distribution sectors, and track records of unlocking shareholder value. "We are proposing a slate of high-caliber, independent director nominees
SCHEDULE 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
SD - RADIUS RECYCLING, INC. (0000912603) (Filer)
Ferrous and Finished Steel Sales Volumes Up Year-Over-Year Positive Operating and Free Cash Flow Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) ("Radius" or the "Company") today reported results for the second quarter of fiscal 2025 ended February 28, 2025. The Company reported a loss per share from continuing operations of $(1.15) and a net loss of $(33) million in the second quarter of fiscal 2025, compared to ($1.19) and ($34) million, respectively, in the prior year second quarter. Adjusted EBITDA was approximately break-even in the second quarter of fiscal 2025, compared to $3 million in the prior ye
PORTLAND, Ore., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2025 ended November 30, 2024. The Company reported a loss per share from continuing operations of $(1.30) and a net loss of $(37) million in the first quarter of fiscal 2025, compared to ($0.64) and ($18) million, respectively, in the prior year first quarter, with the difference substantially driven by a detriment on income tax in the current quarter. Adjusted EBITDA was break-even in the first quarter of fiscal 2025, compared to $1 million in the prior year first quarter. Adjusted loss per share from continuing operations was $(1.33) in the firs
PORTLAND, Ore., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2025 ended November 30, 2024 on Wednesday, January 8, 2025. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Re
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
Goldman initiated coverage of Radius Recycling with a rating of Neutral and set a new price target of $22.00
Seaport Research Partners upgraded Radius Recycling from Sell to Neutral
Seaport Research Partners downgraded Radius Recycling from Neutral to Sell and set a new price target of $17.50
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Tentative Approval' on 10/28/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
PORTLAND, Ore., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today announced the appointment of Marc Hathhorn as Executive Vice President and Chief Operating Officer, effective November 1, 2024. Hathhorn joins Radius from Peabody Energy Corporation (NYSE:BTU) and brings more than 30 years of leadership experience in the mining industry. Most recently, Hathhorn held the position of President--Global Operations at Peabody Energy Corporation (NYSE:BTU), overseeing 5,000 employees and 17 coal mines across the U.S. and Australia. Under Hathhorn's leadership, Peabody achieved multiple safety performance awards, exceeded environmental management and compliance goals, an
PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that its Board of Directors has appointed Mauro Gregorio, the recently retired President of the Performance Materials & Coatings Division at Dow Inc. (NYSE:DOW), as a new independent director, effective November 1, 2024. Mr. Gregorio will serve on the Audit Committee and the Compensation and Human Resources Committee of the Board. Over his nearly 40-year career at Dow, Mr. Gregorio served in multiple roles, including leading the post-acquisition integration of Dow Corning, overseeing the company's feedstock and energy business unit, and serving as global Vice President for the Hygiene and Medi
Urges Stockholders to Vote "FOR" Radius' Highly Qualified, Independent Director Nominees – Catherine J. Friedman, Jean-Pierre Garnier, Ph.D. and Andrew C. von Eschenbach, M.D. – on the BLUE Proxy Card Details Company's Significant Progress Since 2020, Under Refreshed Board and Management Team BOSTON, June 06, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission ("SEC") for its upcoming Annual Meeting of Stockholders, which will be held online on July 8, 2022. Stockholders of record as of June 3, 2022, will be entitled to vote at the meeting. In c